Metabolic syndrome, insulin resistance, and atherosclerosis in Japanese type 2 diabetic patients

Metabolism: Clinical and Experimental

Volumn 56, Issue 8, 2007, Pages 1099-1103

  Taniguchi, Ataru ^a,d   Fukushima, Mitsuo ^b   Kuroe, Akira ^a   Sakaguchi, Kenji ^a   Hashimoto, Hiroko ^a   Yoshioka, Ikuko ^a   Kitatani, Naomi ^a   Tsuji, Tomoko ^a   Ohya, Michihiro ^a   Ohgushi, Minako ^a   Nagasaka, Shoichiro ^c   Isogai, Okihisa ^d   Nakai, Yoshikatsu ^e   Inagaki, Nobuya ^f   Seino, Yutaka ^a  

^a KANSAI DENRYOKU HOSPITAL   (Japan)

^b FOUNDATION FOR BIOMEDICAL RESEARCH AND INNOVATION   (Japan)

^c JICHI MEDICAL UNIVERSITY   (Japan)

^d Isogai Medical Clinic   (Japan)

^e Karasumaoike Nakai Clinic   (Japan)

^f KYOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; GLYCOSYLATED HEMOGLOBIN; INSULIN; LEPTIN; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGE DISTRIBUTION; ANKLE BRACHIAL INDEX; ARTICLE; ATHEROSCLEROSIS; CAROTID ARTERY; CAROTID ARTERY OBSTRUCTION; CONTROLLED STUDY; DIABETIC PATIENT; DIASTOLIC BLOOD PRESSURE; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; JAPANESE; MAJOR CLINICAL STUDY; MALE; MEDICAL SOCIETY; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PULSE WAVE; SEX DIFFERENCE; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE;

ADULT; AGED; ATHEROSCLEROSIS; BLOOD GLUCOSE; BODY MASS INDEX; BRACHIAL ARTERY; CAROTID ARTERIES; DIABETES MELLITUS, TYPE 2; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HOMEOSTASIS; HUMANS; INSULIN; INSULIN RESISTANCE; JAPAN; LEPTIN; LIPIDS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; REGIONAL BLOOD FLOW; TUMOR NECROSIS FACTOR-ALPHA;

EID: 34347397141     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2006.07.027     Document Type: Article

References (32)

1. Gerich J.E. The genetic basis of type 2 diabetes mellitus: impaired insulin secretion versus impaired insulin sensitivity (review). Endocr Rev 19 (1998) 491-503
2. Bergman R.N. Toward physiological understanding of glucose tolerance: minimal-model approach. Diabetes 38 (1989) 1512-1527
3. Welch S., Gebhart S.S.P., Bergman R.N., and Phillips L.S. Minimal model analysis of intravenous glucose tolerance test-derived insulin sensitivity in diabetic subjects. J Clin Endocrinol Metab 71 (1990) 1508-1518
4. Taniguchi A., Nakai Y., Fukushima M., Kawamura H., Imura H., Nagata I., et al. Pathogenic factors responsible for glucose tolerance in patients with NIDDM. Diabetes 41 (1992) 1540-1546
5. Nagasaka S., Tokuyama K., Kusaka I., Hayashi H., Rokkaku K., Nakamura T., et al. Endogenous glucose production and glucose effectiveness in type 2 diabetic subjects derived from stable-labeled minimal model approach. Diabetes 48 (1999) 1054-1060
6. Taniguchi A., Nakai Y., Tokuyama K., Sakai M., Doi K., Fukushima M., et al. Role of glucose effectiveness in the evolution of NIDDM. In: Berman R.N., and Lovejoy J.C. (Eds). The minimal model approach and determinants of glucose tolerance vol. 7 (1997), Louisiana State University Press 357-367
7. Haffner S.M., D'Agostino Jr. R., Mykkanen L., Tracy R., Howard B., Rewers M., et al. Insulin sensitivity in subjects with type 2 diabetes: relationship to cardiovascular risk factors: the Insulin Resistance Atherosclerosis Study. Diabetes Care 22 (1999) 562-568
8. Fukushima M., Usami M., Ikeda M., Nakai Y., Taniguchi A., Suzuki H., et al. Insulin secretion and insulin sensitivity at different stages of glucose tolerance: a cross-sectional study of Japanese type 2 diabetes. Metabolism 53 (2004) 831-835
9. Taniguchi A., Fukushima M., Sakai M., Kataoka K., Nagata I., Doi K., et al. The role of the body mass index and triglyceride levels in identifying insulin-sensitive and insulin-resistant variants in Japanese non-insulin-dependent diabetic patients. Metabolism 49 (2000) 1001-1005
10. Taniguchi A., Fukushima M., Sakai M., Miwa K., Makita T., Nagata I., et al. Remnant-like particle cholesterol, triglycerides, and insulin resistance in nonobese Japanese type 2 diabetic patients. Diabetes Care 23 (2000) 1766-1769
11. Yatagai T., Nagasaka S., Fukushima M., Taniguchi A., Nakamura T., Kuroe A., et al. Hypoadiponectinemia is associated with visceral fat accumulation and insulin resistance in subjects with type 2 diabetes mellitus. Metabolism 52 (2003) 1274-1278
12. Okumura T., Taniguchi A., Nagasaka S., Sakai M., Fukushima M., Kuroe A., et al. Relationship of regional adiposity to serum leptin level in nonobese Japanese type 2 diabetic male patients. Diabetes Metab 29 (2003) 15-18
13. Taniguchi A., Nakai Y., Sakai M., Yoshii S., Hamanaka D., Hatae Y., et al. Relationship of regional adiposity to insulin resistance and serum triglyceride levels in nonobese Japanese type 2 diabetic patients. Metabolism 51 (2002) 544-548
14. Fontbonne A., Eschwege E., Cambien F., Richard J.L., Ducinetiere P., Thibult N., et al. Hypertriglyceridaemia as a risk factor of coronary heart disease mortality in subjects with impaired glucose tolerance or diabetes: results from the 11-year follow-up of the Paris Prospective Study. Diabetologia 32 (1989) 300-304
15. Shinada K., Miyazaki T., and Daida H. Adiponectin and atherosclerotic disease. Clin Chim Acta 344 (2004) 1-12
16. Wallace A.M., McMahon A.D., Packard C.J., MIBiol A.K., Shepherd J., et al. Plasma leptin and the risk of cardiovascular disease in the West of Scotland Coronary Prevention Study (WOSCOPS). Circulation 104 (2001) 3052-3056
17. Isomaa B., Almgren P., Tuomi T., Forsen B., Lahti K., Nissen M., et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 24 (2002) 683-689
18. Pouliot M.C., Despres J.P., Lemieux S., Moorjani S., Bouchard C., Tremblay A., et al. Waist circumference and abdominal sagittal diameter: best simple anthropometric indexes of abdominal visceral adipose tissue accumulation and related cardiovascular risk in men and women. Am J Cardiol 73 (1994) 460-468
19. World Health Organization. Diabetes mellitus: report of a WHO study group (1985), World Health Org, Geneva [Tech. Rep. Ser., no. 727]
20. Ohya M., Taniguchi A., Fukushima M., Nakai Y., Kawasaki Y., Nagasaka S., et al. Three measures of tumor necrosis factor-alpha activity and insulin resistance in non-obese Japanese type 2 diabetic patients. Metabolism 54 (2005) 1297-1301
21. Matthews D.R., Hosker J.P., Rudenski A.S., Naylor B.A., Treacher D.F., and Turner R.C. Homeostasis model assessment: insulin resistance and B-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28 (1985) 412-419
22. Bonora E., Targher G., Alberiche M., Bonadonna R.C., Saggiani F., Zenere M., et al. Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity. Diabetes Care 23 (2000) 57-63
23. Emoto M., Nishizawa Y., Maekawa K., Hiura Y., Kanda H., Kawagichi T., et al. Homeostasis model assessment as a clinical index of insulin resistance in type 2 diabetic patients treated with sulfonylureas. Diabetes Care 22 (1999) 818-822
24. Taniguchi A., Nishimura F., Murayama Y., Nagasaka S., Fukushima M., Sakai M., et al. Porphyromonas gingivalis infection is associated with carotid atherosclerosis in non-obese Japanese type 2 diabetic patients. Metabolism 52 (2003) 142-145
25. Chaiken R.L., Banerji M.A., Pasmantier R.M., Huey H., Hirsch S., and Lebovitz H.E. Patterns of glucose and lipid abnormalities in black NIDDM subject. Diabetes Care 14 (1991) 1036-1042
26. Fujimoto W.Y., Bergstrom R.W., Boyko E.J., Chen K.-W., Leonetti D.L., Newell-Morris L., et al. Visceral adiposity and incident coronary heart disease in Japanese-American men. The 10-year follow-up results of the Seattle Japanese-American Community Diabetes Study. Diabetes Care 22 (1999) 1808-1812
27. Guha M., Bai W., Nadler J., and Natarajan B.R. Molecular mechanisms of alpha gene expression in monocytic cells via hyperglycemia-induced oxidant stress dependent and independent pathways. J Biol Chem 275 (2000) 17728-17735
28. Shai I., Schulze M.B., Manson J.E., Rexrode K.M., Stampfer M.J., Mantzoros C., et al. A prospective study of soluble tumor necrosis factor-α receptor II (sTNF-RII) and risk of coronary heart disease among women with type 2 diabetes. Diabetes Care 28 (2005) 1376-1382
29. Rauchhaus M., Doehner W., Francis D.P., Davos C., Kemp M., Liebenthal C., et al. Plasma cytokine parameters and mortality in patients with chronic heart failure. Circulation 102 (2000) 3060-3067
30. Kawasaki Y., Taniguchi A., Fukushima M., Nakai Y., Kuroe A., Ohya M., et al. Soluble TNF receptors and albuminuria in non-obese Japanese type 2 diabetic patients. Horm Metab Res 37 (2005) 617-621
31. Bruno G., Merletti F., Biggeri A., Bargero G., Ferrero S., Runzo C., et al. Metabolic syndrome as a predictor of all-cause and cardiovascular mortality in type 2 diabetes. The Casale Monferrato Study. Diabetes Care 27 (2004) 2689-2694
32. Kahn R., Buse J., Ferrannini E., and Stern M. The metabolic syndrome: time for a critical appraisal. Joint statement from the American Diabetes Association and the European Association for the study of diabetes. Diabetes Care 28 (2005) 2289-2304